Caption Management’s AbbVie ABBV Stock Holding History

Caption Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,000	Closed	-$21.7M	–	1600
2026 Q1	$21.7M	Buy	+100,000	New	+$22.2M	0.13%	171
2025 Q4	–	Sell	-198,000	Closed	-$45.8M	–	1519
2025 Q3	$45.8M	Buy	+198,000	New	+$40.3M	0.36%	51
2025 Q2	–	Sell	-59,000	Closed	-$12.4M	–	1384
2025 Q1	$12.4M	Buy	+59,000	New	+$11.5M	0.12%	155
2024 Q1	–	Sell	-55,000	Closed	-$8.52M	–	1128
2023 Q4	$8.52M	Hold	55,000	–	–	0.11%	206
2023 Q3	$8.2M	Hold	55,000	–	–	0.13%	194
2023 Q2	$7.41M	Buy	55,000 +25,000	+83%	+$3.67M	0.13%	202
2023 Q1	$4.78M	Buy	+30,000	New	+$4.59M	0.09%	242
2019 Q2	–	Sell	-65,000	Closed	-$5.24M	–	642
2019 Q1	$5.24M	Buy	+65,000	New	+$5.32M	0.29%	103

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Caption Management's ABBV Position: Q2 2026 in Review

Caption Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 33,700 shares — an estimated $7.25M sold.

Caption Management first reported a position in ABBV in Q1 2019 and held it in 8 quarters. The position peaked at $10.2M in Q4 2021. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Caption Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Caption Management sold 33,700 AbbVie shares in Q2 2026, an estimated $7.25M.
Caption Management first reported a position in AbbVie in Q1 2019 and held it in 8 quarters.
Caption Management's AbbVie position peaked at $10.2M in Q4 2021.
4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.